BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6243538)

  • 1. Examination of interspecies differences in renal and skeletal receptor binding and adenylate cyclase stimulation with human calcitonin.
    Goltzman D
    Endocrinology; 1980 Feb; 106(2):510-8. PubMed ID: 6243538
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal receptors for calcitonin: coordinate occurrence with calcitonin-activated adenylate cyclase.
    Marx SJ; Aurbach GD
    Endocrinology; 1975 Aug; 97(2):448-53. PubMed ID: 169126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional properties of parathyroid hormone receptors.
    Nissenson RA
    Miner Electrolyte Metab; 1982; 8(3-4):151-8. PubMed ID: 6300627
    [No Abstract]   [Full Text] [Related]  

  • 4. Coupling of the canine renal parathyroid hormone receptor to adenylate cyclase: modulation by guanyl nucleotides and N-ethylmaleimide.
    Teitelbaum AP; Nissenson RA; Arnaud CD
    Endocrinology; 1982 Nov; 111(5):1524-33. PubMed ID: 6290186
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased binding of calcitonin to renal receptors in parathyroidectomized rats.
    Sraer J; Ardaillou R; Couette S
    Endocrinology; 1974 Aug; 95(2):632-7. PubMed ID: 4368809
    [No Abstract]   [Full Text] [Related]  

  • 6. Mobile receptor and collision coupling mechanisms for the activation of adenylate cyclase by glucagon.
    Houslay MD
    Adv Cyclic Nucleotide Res; 1981; 14():111-9. PubMed ID: 6269373
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of thyroid adenylate cyclase: guanyl nucleotide modulation of thyrotropin receptor-adenylate cyclase function.
    Saltiel AR; Powell-Jones CH; Thomas CG; Nayfeh SN
    Endocrinology; 1981 Nov; 109(5):1578-89. PubMed ID: 6271536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologically active, derivatizable salmon calcitonin analog: design, synthesis, and applications.
    D'Santos CS; Nicholson GC; Moseley JM; Evans T; Martin TJ; Kemp BE
    Endocrinology; 1988 Sep; 123(3):1483-8. PubMed ID: 2841096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat kidney cells in primary culture: interaction of salmon calcitonin with receptor sites.
    Chao WT; Forte LR
    Endocrinology; 1983 Feb; 112(2):745-52. PubMed ID: 6293809
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenosine receptors and the regulation of adenylate cyclase.
    Wolff J; Londos C; Cooper DM
    Adv Cyclic Nucleotide Res; 1981; 14():199-214. PubMed ID: 6269379
    [No Abstract]   [Full Text] [Related]  

  • 11. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
    Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
    Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of adenylate cyclase by amylin in CHO-K1 cells.
    D'Santos CS; Gatti A; Poyner DR; Hanley MR
    Mol Pharmacol; 1992 May; 41(5):894-9. PubMed ID: 1375316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal receptors of parathyroid hormone and calcitonin (author's transl)].
    Ardaillou R
    Nouv Presse Med; 1978 Dec; 7(45):4125-30. PubMed ID: 218163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenylate cyclase activation and competitive binding with renal tissue using synthetic eel calcitonin analog and its fragments.
    Yamamoto I; Morita R; Fukunaga M; Dokoh S; Shigeno C; Torizuka K; Noda T
    Endocrinology; 1981 Feb; 108(2):698-702. PubMed ID: 7449744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanyl nucleotide potentiation of parathyroid hormone-stimulated adenylate cyclase in chicken renal plasma membranes: a receptor-independent effect.
    Nissenson RA; Nyiredy KO; Arnaud CD
    Endocrinology; 1981 May; 108(5):1949-53. PubMed ID: 6260469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of a calcitonin receptor and adenylate cyclase in BEN cells, a human cancer cell line.
    Findlay DM; deLuise M; Michelangeli VP; Ellison M; Martin TJ
    Cancer Res; 1980 Apr; 40(4):1311-7. PubMed ID: 6244091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure of adenylate cyclase systems.
    Rodbell M; Lad PM; Nielsen TB; Cooper DM; Schlegel W; Preston MS; Londos C; Kempner ES
    Adv Cyclic Nucleotide Res; 1981; 14():3-14. PubMed ID: 6269384
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of forskolin with resolved adenylate cyclase components.
    Bender JL; Wolf LG; Neer EJ
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():101-9. PubMed ID: 6328911
    [No Abstract]   [Full Text] [Related]  

  • 19. beta-Adrenergic receptor: ligand binding properties and the interaction with adenylyl cyclase.
    Maguire ME; Ross EM; Gilman AG
    Adv Cyclic Nucleotide Res; 1977; 8():1-83. PubMed ID: 21549
    [No Abstract]   [Full Text] [Related]  

  • 20. Photoaffinity labeling of rat calcitonin gene-related peptide receptors and adenylate cyclase activation: identification of receptor subtypes.
    Stangl D; Muff R; Schmolck C; Fischer JA
    Endocrinology; 1993 Feb; 132(2):744-50. PubMed ID: 8381072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.